(R)-4-((Diethylamino)methyl)-N-(2-methoxyphenethyl)-N-(pyrrolidin-3-yl)benzamide dihydrochloride
≥98%
- Product Code: 99216
Alias:
PF-429242 dihydrochloride
CAS:
947303-87-9
| Molecular Weight: | 409.56 (free base) g./mol | Molecular Formula: | C₂₅H₃₅N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of therapeutic agents targeting neurological disorders. Its structure suggests potential activity as a modulator of neurotransmitter systems, making it a candidate for research in treating conditions like depression, anxiety, or cognitive impairments. The presence of functional groups such as diethylamino and pyrrolidinyl moieties indicates its ability to interact with receptors or enzymes in the central nervous system. Researchers explore its efficacy in preclinical studies to assess its pharmacological profile, including binding affinity, selectivity, and metabolic stability. Additionally, it may serve as a lead compound for further optimization to enhance its therapeutic potential and reduce off-target effects.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white to beige powder |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿2,830.00 |
+
-
|
| 0.005 | 10-20 days | ฿10,250.00 |
+
-
|
| 0.025 | 10-20 days | ฿32,990.00 |
+
-
|
(R)-4-((Diethylamino)methyl)-N-(2-methoxyphenethyl)-N-(pyrrolidin-3-yl)benzamide dihydrochloride
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of therapeutic agents targeting neurological disorders. Its structure suggests potential activity as a modulator of neurotransmitter systems, making it a candidate for research in treating conditions like depression, anxiety, or cognitive impairments. The presence of functional groups such as diethylamino and pyrrolidinyl moieties indicates its ability to interact with receptors or enzymes in the central nervous system. Researchers explore its efficacy in preclinical studies to assess its pharmacological profile, including binding affinity, selectivity, and metabolic stability. Additionally, it may serve as a lead compound for further optimization to enhance its therapeutic potential and reduce off-target effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :